{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:17:39Z","timestamp":1772727459919,"version":"3.50.1"},"reference-count":59,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"DOI":"10.1210\/jc.2013-1512","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T10:06:36Z","timestamp":1389693996000},"page":"E497-E507","source":"Crossref","is-referenced-by-count":79,"title":["Cell Cycle Deregulation and<i>TP53<\/i>and<i>RAS<\/i>Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas"],"prefix":"10.1210","volume":"99","author":[{"given":"Jaime Miguel","family":"Pita","sequence":"first","affiliation":[{"name":"Unidade de Investiga\u00e7\u00e3o em Patobiologia Molecular (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), 1099\u2013023 Lisboa, Portugal"},{"name":"Centro de Estudos de Doen\u00e7as Cr\u00f3nicas (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, 1169\u2013056 Lisboa, Portugal"}]},{"given":"In\u00eas Filipa","family":"Figueiredo","sequence":"additional","affiliation":[{"name":"Unidade de Investiga\u00e7\u00e3o em Patobiologia Molecular (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), 1099\u2013023 Lisboa, Portugal"},{"name":"Centro de Estudos de Doen\u00e7as Cr\u00f3nicas (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, 1169\u2013056 Lisboa, Portugal"}]},{"given":"Margarida Maria","family":"Moura","sequence":"additional","affiliation":[{"name":"Unidade de Investiga\u00e7\u00e3o em Patobiologia Molecular (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), 1099\u2013023 Lisboa, Portugal"},{"name":"Centro de Estudos de Doen\u00e7as Cr\u00f3nicas (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, 1169\u2013056 Lisboa, Portugal"}]},{"given":"Valeriano","family":"Leite","sequence":"additional","affiliation":[{"name":"Unidade de Investiga\u00e7\u00e3o em Patobiologia Molecular (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), 1099\u2013023 Lisboa, Portugal"},{"name":"Servi\u00e7o de Endocrinologia (V.L.), Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, 1099\u2013023 Lisboa, Portugal"},{"name":"Centro de Estudos de Doen\u00e7as Cr\u00f3nicas (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, 1169\u2013056 Lisboa, Portugal"}]},{"given":"Branca Maria","family":"Cavaco","sequence":"additional","affiliation":[{"name":"Unidade de Investiga\u00e7\u00e3o em Patobiologia Molecular (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), 1099\u2013023 Lisboa, Portugal"},{"name":"Centro de Estudos de Doen\u00e7as Cr\u00f3nicas (J.M.P., I.F.F., M.M.M., V.L., B.M.C.), Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, 1169\u2013056 Lisboa, Portugal"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114133829600_B1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1677\/ERC-08-0154","article-title":"Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies","volume":"16","author":"Smallridge","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B2","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1245\/s10434-007-9503-8","article-title":"Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma","volume":"14","author":"Wang","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"key\n\t\t\t\t2019041114133829600_B3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/jc.2007-1076","article-title":"Phosphatidylinositol 3-kinase\/akt and ras\/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer","volume":"93","author":"Santarpia","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114133829600_B4","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.21073","article-title":"Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations","volume":"103","author":"Quiros","year":"2005","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9440(10)64045-X","article-title":"\u03b2-Catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis","volume":"158","author":"Garcia-Rostan","year":"2001","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2019041114133829600_B6","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1158\/0008-5472.CAN-04-4259","article-title":"Mutation of the PIK3CA gene in anaplastic thyroid cancer","volume":"65","author":"Garcia-Rostan","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B7","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.1158\/0008-5472.CAN-07-1887","article-title":"A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma","volume":"67","author":"Salvatore","year":"2007","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/sj.onc.1210792","article-title":"Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information","volume":"27","author":"Montero-Conde","year":"2008","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041114133829600_B9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/thy.2006.16.161","article-title":"Gene expression in poorly differentiated papillary thyroid carcinomas","volume":"16","author":"Fluge","year":"2006","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041114133829600_B10","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.bjc.6605340","article-title":"Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas","volume":"101","author":"Pita","year":"2009","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1089\/thy.2004.14.1020","article-title":"Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers","volume":"14","author":"Kurihara","year":"2004","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041114133829600_B12","first-page":"50","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs","author":"DeLellis","year":"2004"},{"key":"key\n\t\t\t\t2019041114133829600_B13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"key\n\t\t\t\t2019041114133829600_B14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114133829600_B15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/geno.2002.6698","article-title":"Profiling gene expression using onto-express","volume":"79","author":"Khatri","year":"2002","journal-title":"Genomics"},{"key":"key\n\t\t\t\t2019041114133829600_B16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1101\/gr.6202607","article-title":"A systems biology approach for pathway level analysis","volume":"17","author":"Draghici","year":"2007","journal-title":"Genome Res"},{"key":"key\n\t\t\t\t2019041114133829600_B17","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114133829600_B18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114133829600_B19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jso.21803","article-title":"The concepts in poorly differentiated carcinoma of the thyroid: a review article","volume":"103","author":"Nambiar","year":"2011","journal-title":"J Surg Oncol"},{"key":"key\n\t\t\t\t2019041114133829600_B20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00000658-200003000-00005","article-title":"Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21","volume":"231","author":"Lam","year":"2000","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t2019041114133829600_B21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/cncr.20087","article-title":"Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients","volume":"100","author":"Volante","year":"2004","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B22","doi-asserted-by":"crossref","first-page":"e37807","DOI":"10.1371\/journal.pone.0037807","article-title":"mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch","volume":"7","author":"H\u00e9brant","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041114133829600_B23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.bjc.6603578","article-title":"Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines","volume":"96","author":"Rodrigues","year":"2007","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1677\/erc.1.00818","article-title":"Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes","volume":"11","author":"Onda","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Huber","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"key\n\t\t\t\t2019041114133829600_B26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjsurg.2006.02.005","article-title":"Derangement of the E-cadherin\/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma","volume":"191","author":"Wiseman","year":"2006","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t2019041114133829600_B27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/modpathol.3800235","article-title":"Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors","volume":"18","author":"Prasad","year":"2005","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t2019041114133829600_B28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","article-title":"Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast","volume":"145","author":"Scheel","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019041114133829600_B29","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1158\/0008-5472.CAN-09-1248","article-title":"The BRAFV600E oncogene induces transforming growth factor \u03b2 secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer","volume":"69","author":"Riesco-Eizaguirre","year":"2009","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B30","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1073\/pnas.0610733104","article-title":"Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion","volume":"104","author":"Vasko","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114133829600_B31","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/onc.2011.44","article-title":"Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGF\u03b2 signaling","volume":"30","author":"Knauf","year":"2011","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041114133829600_B32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B33","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1158\/0008-5472.CAN-06-0479","article-title":"Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition","volume":"66","author":"Moreno-Bueno","year":"2006","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B34","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1038\/onc.2010.218","article-title":"Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041114133829600_B35","doi-asserted-by":"crossref","first-page":"16218","DOI":"10.1074\/jbc.M110.214585","article-title":"Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions","volume":"286","author":"Zhang","year":"2011","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114133829600_B36","first-page":"1811","article-title":"Frequent mutation and nuclear localization of \u03b2-catenin in anaplastic thyroid carcinoma","volume":"59","author":"Garcia-Rostan","year":"1999","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B37","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2559.2003.01642.x","article-title":"E-cadherin loss rather than \u03b2-catenin alterations is a common feature of poorly differentiated thyroid carcinomas","volume":"42","author":"Rocha","year":"2003","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t2019041114133829600_B38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"CDK inhibitors: cell cycle regulators and beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev Cell"},{"key":"key\n\t\t\t\t2019041114133829600_B39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.0.CO;2-1","article-title":"Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines","volume":"67","author":"Calabr\u00f2","year":"1996","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1078\/0344-0338-00436","article-title":"Hypermethylation of the CDKN2\/p16INK4A promoter in thyroid carcinogenesis","volume":"199","author":"Boltze","year":"2003","journal-title":"Pathol Res Pract"},{"key":"key\n\t\t\t\t2019041114133829600_B41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejca.2006.08.025","article-title":"An immunohistochemical study of p16(INK4a) expression in multistep thyroid tumourigenesis","volume":"43","author":"Ball","year":"2007","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1098-2744(199601)15:1<5::AID-MC2>3.0.CO;2-K","article-title":"Infrequent CDKN2 mutation in human differentiated thyroid cancers","volume":"15","author":"Tung","year":"1996","journal-title":"Mol Carcinog"},{"key":"key\n\t\t\t\t2019041114133829600_B43","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/MCB.20.5.1723-1732.2000","article-title":"Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression","volume":"20","author":"Lee","year":"2000","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t2019041114133829600_B44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/0008-5472.CAN-06-2478","article-title":"Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma","volume":"67","author":"Yu","year":"2007","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B45","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-06-1125","article-title":"Genetic alterations and their relationship in the phosphatidylinositol 3-kinase\/Akt pathway in thyroid cancer","volume":"13","author":"Hou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B46","first-page":"4710","article-title":"Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors","volume":"57","author":"Dahia","year":"1997","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/gcc.10098","article-title":"Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer","volume":"35","author":"Frisk","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B48","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1210\/jc.2003-030838","article-title":"BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114133829600_B49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00428-004-1018-0","article-title":"BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas","volume":"444","author":"Soares","year":"2004","journal-title":"Virchows Arch"},{"key":"key\n\t\t\t\t2019041114133829600_B50","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1210\/jc.2009-1233","article-title":"RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact","volume":"94","author":"Volante","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114133829600_B51","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1200\/JCO.2003.10.130","article-title":"Ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer","volume":"21","author":"Garcia-Rostan","year":"2003","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041114133829600_B52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Tsiatis","year":"2010","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t2019041114133829600_B53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1756-9966-31-79","article-title":"A comparison of direct sequencing, pyrosequencing, high resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas","volume":"31","author":"Jancik","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041114133829600_B54","doi-asserted-by":"crossref","first-page":"e19601","DOI":"10.1371\/journal.pone.0019601","article-title":"Benchmarking of mutation diagnostics in clinical lung cancer specimens","volume":"6","author":"Querings","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041114133829600_B55","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1677\/ERC-08-0036","article-title":"Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer","volume":"15","author":"Ryder","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019041114133829600_B56","doi-asserted-by":"crossref","first-page":"e22567","DOI":"10.1371\/journal.pone.0022567","article-title":"Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma","volume":"6","author":"Caillou","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041114133829600_B57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.semcancer.2010.02.006","article-title":"Therapeutic targeting of p53 by small molecules","volume":"20","author":"Selivanova","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"key\n\t\t\t\t2019041114133829600_B58","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00432-011-1039-4","article-title":"The CDK inhibitors in cancer research and therapy","volume":"137","author":"Cicenas","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"key\n\t\t\t\t2019041114133829600_B59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/path.2785","article-title":"The dynamic roles of TGF-\u03b2 in cancer","volume":"223","author":"Meulmeester","year":"2011","journal-title":"J Pathol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/3\/E497\/11158172\/jcemE497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T13:24:56Z","timestamp":1565097896000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/3\/E497\/2537352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-1512","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]}}}